Compositions comprising
The present disclosure provides for compositions combining Cannabinoid Fractions and Mushroom Extract Fractions for recreational and medicinal uses. The disclosed compositions are useful for treating symptoms of anxiety, stress, pain, and promoting sleep. The pharmaceutical compositions comprise particular cannabinoid ratios and terpene profiles.
1. A capsule comprising:
i. a Cannabinoid Fraction comprising purified cannabidiol (CBD) and purified cannabigerol (CBG);
ii. a Mushroom Extract Fraction comprising Hericium ernaceus and Cordyceps militaris ; and
iii. a Terpene Fraction.
2. The capsule of claim 1 , wherein the Terpene Fraction comprises:
at least two terpenes selected from the group consisting of: alpha pinene, limonene, beta-pinene, alpha phellandrene, terpinolene, nerolidol, nerol, myrcene, and beta caryophyllene.
3. The capsule of claim 1 , wherein the Terpene Fraction comprises: alpha pinene, limonene, beta-pinene, alpha phellandrene, terpinolene, nerolidol, and nerol.
4. The capsule of claim 1 , comprising guarana.
5. The capsule of claim 1 , comprising from about 10 mg to about 20 mg of CBD.
6. The capsule of claim 1 , comprising about 15 mg of CBD.
7. The capsule of claim 1 , comprising from about 10 mg to about 30 mg of CBG.
8. The capsule of claim 1 , comprising about 20 mg of CBG.
9. The capsule of claim 1 , comprising from about 100 to about 200 mg of Hericium ernaceus.
10. The capsule of claim 1 , comprising about 150 mg of Hericium ernaceus.
11. The capsule of claim 1 , comprising from about 100 to about 200 mg of Cordyceps militaris.
12. The capsule of claim 1 , comprising about 150 mg of Cordyceps militaris.
13. The capsule of claim 1 , wherein the Hericium ernaceus and Cordyceps militaris are present in a ratio of about 1:1 by weight.
14. The capsule of claim 1 , wherein the CBD and CBG are present in a ratio of about 3:4 by weight.
15. The capsule of claim 1 , wherein the Terpene Fraction comprises alpha pinene, limonene, beta-pinene, alpha phellandrene, terpinolene, nerolidol, and nerol; wherein CBD and CBG are present in a ratio of about 3:4 by weight; and wherein Hericium ernaceus and Cordyceps militaris are present in a ratio of about 1:1 by weight.